Current Edition

Current features

Conducting Clinical Trials in the Parallel Virtual Universe

Quantitative systems pharmacology (QSP) and physiologically based pharmacokinetic (PBPK) modelling can be employed to create a parallel virtual workflow throughout d...
Continue Reading →
Current features

Advancing Research and Development of Multi-indication and Combination Therapies for Obesity

Obesity is commonly defined as excess fat accumulation that puts someone at a higher risk for adverse health outcomes.1 The simplicity of this definition can be misl...
Continue Reading →
Volume 15 Issue 4

Achieving GCP Compliance in Oncology Trials: The Balance between Obligation, Idealism and Realism

Compliance with GCP provides assurance that the data and reported results of clinical investigations are credible and accurate and that the rights, safety, and confi...
Continue Reading →
Volume 15 Issue 4

Revolutionising Hypertension Management Through Personalised, Data-driven Dose Optimisation

In the late 1990s, Pfizer’s revenue stream was predominantly fuelled from the sales of antihypertensive drugs. The climax, so to speak, of its rigorous anti-hyperten...
Continue Reading →
Volume 15 Issue 4

Paving the Way for a Robust Research Ethics Review Structure in Malaysia

Introduction The foundation of good research is built on sound ethical principles, which require a good rationale, a solid methodology and proper consideration of...
Continue Reading →
Volume 14 Issue 6

Improving Clinical Study Publishing Success

Academic publishing is highly competitive, and this competition is only growing as more and more research papers are being submitted to top journals – submissions to ...
Continue Reading →
Regional News

Abzena nabs $65M to bolster manufacturing and research services on both sides of the pond

Roughly one year after dropping designs on a $200 million biologics plant in North Carolina, antibody-drug conjugate specialist Abzena has snared a fresh round of fun...
Continue Reading →
Volume 13 Issue 5

Overview: Pharmacovigilance and Risk Management

Drug development is an expensive, lengthy, and high-risk business taking 1015 years and is associated with a high attrition rate. Approximately only 1 in 10 drugs tha...
Continue Reading →
The Digital World of Clinical Research
Volume 10 Issue 6

The Digital World of Clinical Research

Shiyan Caan of SQN Health examines the tools and services which provide the clinical trial market with the ability to adapt to a changing environment. With an abundan...
Continue Reading →
Asia Pacific

Hadassah Medical Center Joins TriNetX to Increase Clinical Trial Collaboration Efforts with Pharma

Hadassah Medical Center, a leading healing, teaching, and research hospital in Jerusalem, Israel, is the first medical center in the country to join the TriNetX globa...
Continue Reading →